From Inspiration to Recognition: ASCO Awards FASCO Title to Gevorg Tamamyan
Gevorg Tamamyan, Co-founder and Editor in Chief of OncoDaily, posted on LinkedIn:
”It is a great honor to be named a Fellow of the American Society of Clinical Oncology (FASCO) – a recognition bestowed upon ASCO members who have shown extraordinary dedication through their voluntary efforts to benefit the Society, the specialty of oncology, and, most importantly, the patients we serve.
Years ago, when I first set foot at ASCO’s Annual Meeting – when all of Chicago was alive with the movement of nearly fifty thousand oncologists and members from around the world – I remember watching, in awe, as the world’s leading experts, whose names I had only read in books, were called to the stage to receive the title of FASCO. I could never have imagined that one day…
What can I say – I am deeply grateful to everyone who, in one way or another, directly or indirectly, has helped make this day possible.
It is, indeed, a great honor – and an even greater responsibility.”

Keep up with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?